Amgen operates in a challenging environment characterized by external pressures, including increased competition from biosimilars and generics, rising healthcare costs, and uncertain macroeconomic conditions. The company has demonstrated operational flexibility and resilience by maintaining critical business operations during the COVID-19 pandemic, with remote working arrangements not significantly affecting its ability to supply medicines. Amgen's strategy involves integrated activities intended to strengthen its competitive position in the biotechnology industry, focusing on resource allocation and capital management to support innovation and business continuity. The company has advanced its innovative pipeline and continued to provide uninterrupted supplies of medicines globally, reflecting its commitment to adaptability and performance maintenance under adverse conditions. Amgen's approach to human capital resource management emphasizes attracting, developing, and retaining talent, which is essential for tackling the challenges of discovery, development, and commercialization of innovative medicines. The company has also set long-term environmental targets to achieve sustainability, indicating a proactive stance towards operational management and community resilience. Additionally, Amgen's financial strategies, including disciplined capital allocation and investment in research and development, are designed to mitigate risks and enhance organizational capabilities. The company's ability to foresee and respond to disruptions, such as those caused by the pandemic, demonstrates its organizational resilience, allowing it to adjust to unexpected situations while maintaining performance. Amgen's commitment to diversity and inclusion fosters an innovative culture that supports its resilience strategies. The company continuously monitors its operational environment and engages in risk assessment to address potential challenges, ensuring that it remains prepared for future uncertainties. Through its strategic initiatives and collaborative networks, Amgen aims to enhance its organizational strength and effectiveness, positioning itself to thrive in a turbulent market landscape. The company's focus on knowledge management and learning processes contributes to its absorptive capacity, enabling it to adapt and evolve in response to complex situations. Overall, Amgen's multifaceted approach to resilience encompasses operational continuity, strategic adaptation, and a commitment to organizational health, ensuring its ability to confront adversity and sustain growth.